Skip to content

Drug interactions

Dabrafenib + Flibanserin

Severity: Moderate

Dabrafenib and Flibanserin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dabrafenib induces CYP3A4 and may substantially reduce flibanserin exposure, leading to loss of efficacy. Flibanserin labeling advises against concomitant use with strong CYP3A4 inducers.

What this interaction means in plain words

Dabrafenib and Flibanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dabrafenib belongs to Oncology; Flibanserin belongs to Genitourinary.

Evidence level: Moderate

Why it happens

CYP3A4 induction increases flibanserin metabolism.

What to do

Avoid the combination where possible and consider whether flibanserin remains useful.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabrafenib and Flibanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabrafenib with Flibanserin?

MediHelp rates the interaction as moderate. Dabrafenib and Flibanserin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dabrafenib induces CYP3A4 and may substantially reduce flibanserin exposure, leading to loss of efficacy. Flibanserin labeling advises against concomitant use with strong CYP3A4 inducers.

How serious is the interaction between Dabrafenib and Flibanserin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and consider whether flibanserin remains useful.

What other medicines interact with Flibanserin?

MediHelp also lists interactions of Flibanserin with, for example, Atazanavir, Ceritinib, Clarithromycin. The full list is on the Flibanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in